These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 10860862

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
    Itoh K, Udagawa N, Matsuzaki K, Takami M, Amano H, Shinki T, Ueno Y, Takahashi N, Suda T.
    J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
    [Abstract] [Full Text] [Related]

  • 3. Mechanical stimulation effects on functional end effectors in osteoblastic MG-63 cells.
    Saunders MM, Taylor AF, Du C, Zhou Z, Pellegrini VD, Donahue HJ.
    J Biomech; 2006 Sep; 39(8):1419-27. PubMed ID: 15953606
    [Abstract] [Full Text] [Related]

  • 4. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ, Wronski TJ, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, Halloran BP.
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
    Chikazu D, Katagiri M, Ogasawara T, Ogata N, Shimoaka T, Takato T, Nakamura K, Kawaguchi H.
    J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
    [Abstract] [Full Text] [Related]

  • 7. Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice.
    Cao J, Venton L, Sakata T, Halloran BP.
    J Bone Miner Res; 2003 Feb; 18(2):270-7. PubMed ID: 12568404
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells.
    Koh JM, Lee YS, Byun CH, Chang EJ, Kim H, Kim YH, Kim HH, Kim GS.
    J Endocrinol; 2005 Jun; 185(3):401-13. PubMed ID: 15930166
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Megakaryocytes modulate osteoblast synthesis of type-l collagen, osteoprotegerin, and RANKL.
    Bord S, Frith E, Ireland DC, Scott MA, Craig JI, Compston JE.
    Bone; 2005 May; 36(5):812-9. PubMed ID: 15794927
    [Abstract] [Full Text] [Related]

  • 12. Regulation of osteoclast differentiation and function by receptor activator of NFkB ligand and osteoprotegerin.
    Shiotani A, Takami M, Itoh K, Shibasaki Y, Sasaki T.
    Anat Rec; 2002 Oct 01; 268(2):137-46. PubMed ID: 12221720
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.
    Sun SG, Lau YS, Itonaga I, Sabokbar A, Athanasou NA.
    J Pathol; 2006 May 01; 209(1):114-20. PubMed ID: 16482498
    [Abstract] [Full Text] [Related]

  • 15. Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction.
    Kanatani M, Sugimoto T, Sowa H, Kobayashi T, Kanzawa M, Chihara K.
    J Cell Physiol; 2004 Oct 01; 201(1):17-25. PubMed ID: 15281085
    [Abstract] [Full Text] [Related]

  • 16. Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells.
    Mancino AT, Klimberg VS, Yamamoto M, Manolagas SC, Abe E.
    J Surg Res; 2001 Sep 01; 100(1):18-24. PubMed ID: 11516200
    [Abstract] [Full Text] [Related]

  • 17. Osteoclast stimulating and differentiating factors in human cholesteatoma.
    Hamzei M, Ventriglia G, Hagnia M, Antonopolous A, Bernal-Sprekelsen M, Dazert S, Hildmann H, Sudhoff H.
    Laryngoscope; 2003 Mar 01; 113(3):436-42. PubMed ID: 12616193
    [Abstract] [Full Text] [Related]

  • 18. Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation.
    Nagai M, Sato N.
    Biochem Biophys Res Commun; 1999 Apr 21; 257(3):719-23. PubMed ID: 10208850
    [Abstract] [Full Text] [Related]

  • 19. Pulsed electromagnetic fields stimulation affects osteoclast formation by modulation of osteoprotegerin, RANK ligand and macrophage colony-stimulating factor.
    Chang K, Chang WH, Huang S, Huang S, Shih C.
    J Orthop Res; 2005 Nov 21; 23(6):1308-14. PubMed ID: 15913941
    [Abstract] [Full Text] [Related]

  • 20. [New paradigms in the regulation of bone metabolism].
    Rosa-Rañal M, de la Cruz DA, Lorena-Rubio Y, Larrea F.
    Rev Invest Clin; 2001 Nov 21; 53(4):362-9. PubMed ID: 11599485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.